Read + Share
Amedeo Smart
Independent Medical Education
Shimizu Y, Maruyama K, Suzuki M, Kawachi H, et al. Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma. Cancer Lett 2022;543:215799.PMID: 35724767
Email
LinkedIn
Facebook
Twitter
Privacy Policy